MedTrace Logo

Urinary Continence After Vaginal Surgery for Genital Prolapse in the Spanish Population.

NCT07628036 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1042

Last updated 2026-06-04

No results posted yet for this study

Summary

Surgical correction of pelvic organ prolapse (POP) may be associated with the development of postoperative stress urinary incontinence (SUI). This clearly affects women's satisfaction and their quality of life, and may require subsequent medical and/or surgical treatments.

On the other hand, pre-existing SUI could resolve after corrective prolapse surgery. Similarly, urge urinary incontinence (UUI) could appear or improve after vaginal POP surgery. Therefore, it is of paramount importance to know the prevalence of urinary incontinence after POP vaginal surgery and incontinence resolution in our population. Identifying the risk factors for the development of urinary incontinence may allow to provide individualized treatment.

Conditions

  • Pelvic Organ Prolapse (POP)
  • Pelvic Organ Prolapse Vaginal Surgery
  • Urinary Incontinence (UI)

Interventions

PROCEDURE

Vaginal surgery for pelvic organ prolapse

Vaginal surgery of any vaginal compartment for pelvic organ prolapse

Sponsors & Collaborators

  • University Hospital Virgen de la Arrixaca, Murcia

    collaborator UNKNOWN

  • Hospital Materno-Infantil de Canarias. Las Palmas de Gran Canaria. Spain

    collaborator UNKNOWN

  • Hospital de l'Esperit Sant

    collaborator UNKNOWN

  • Consorci Sanitari de Terrassa

    collaborator OTHER

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Sabadell Jordi, MD, PhD. · Hospital Universitari Vall d'Hebron Research Institute

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2028-05-30
Completion
2028-05-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07628036 on ClinicalTrials.gov